Overt albuminuria predicts diabetic retinopathy in Hispanics with NIDDM

doi:10.1053/ajkd.1998.v31.pm9631838

American Journal of Kidney Diseases

Volume 31, Issue 6, June 1998, Pages 947-953

https://doi.org/10.1053/ajkd.1998.v31.pm9631838 Get rights and content

Abstract

Non-insulin-dependent diabetes mellitus (NIDDM) occurs with a higher frequency in Hispanic as compared with non-Hispanic whites. It also appears that there is a higher prevalence of diabetic nephropathy in the Hispanic population when compared with non-Hispanic whites. In the current study, 144 Hispanics and 671 non-Hispanic white NIDDM subjects were studied to determine the possible association of various risk factors and diabetic complications, including overt albuminuria, with diabetic retinopathy. Stereoscopic retinal fundus photographs were obtained and graded by the University of Wisconsin Fundus Photographic Reading Center. We also sought to determine whether risk factors for retinopathy vary between Hispanics and non-Hispanic whites. In the total group, duration of diabetes, glycosylated hemoglobin, neuropathy, diastolic hypertension, use of insulin, and Hispanic ethnicity correlated with the presence of retinopathy. Controlling for severity and duration of diabetes, Hispanics had a significantly increased risk of retinopathy relative to non-Hispanic whites (OR = 2.13, 95% CI = 1.34, 3.37, P = 0.0013). Duration of diabetes and presence of neuropathy were significantly correlated with the presence of diabetic retinopathy in Hispanics and non-Hispanic whites. The presence of overt albuminuria (>200 microg/min), although not related to diabetic retinopathy in non-Hispanic whites, conferred a high risk for diabetic retinopathy in Hispanics (OR = 11.14, CI = 1.20, 103.39, P = 0.0339) independent of other risk factors. In summary, Hispanics with NIDDM have an increased prevalence of diabetic retinopathy when compared with non-Hispanic whites. In addition, overt albuminuria in the Hispanic subjects appears to be a powerful predictor of the diabetic retinopathy. (Am J Kidney Dis 1998 Jun;31(6):947-53)

References (0)

Cited by (81)

Association between albuminuria and retinal microvascular dysfunction in type 2 diabetes with and without hypertension
2023, Diabetes Epidemiology and Management
Studies assessing the concordance of albuminuria and retinal microvascular dysfunction (RMD) in type 2 diabetes (T2D) have yielded inconsistent results. Similar to ethnicity, hypertension may be a potential explanatory variable. We compared the association between albuminuria and RMD in West Africans with T2D with and without hypertension.
This was a cross-sectional study among 177 systematically sampled Ghanaians with T2D aged ≥ 35 years. Albuminuria was based on urinary albumin-creatinine ratio≥30 mg/g. Retinal images were analyzed and graded according to the Early Treatment Diabetic Retinopathy Study criteria. Logistic regression was used to examine the associations of albuminuria and RMD with adjustments for age, sex, socioeconomic status, diabetes duration, HbA1c, smoking, systolic blood pressure (BP), BMI, and total cholesterol.
RMD was more prevalent in individuals with albuminuria than in those without albuminuria (41.7% vs. 24.0%, p = 0.026). In the fully adjusted model, albuminuria remained significantly associated with RMD (odds ratio 2.41[95% CI:1.00–5.80], p = 0.049); the association between albuminuria and RMD was more pronounced in individuals with hypertension (3.10 [1.01–9.50], 0.048) than without hypertension (1.70[0.33–8.77],0.523). In analyses stratified by BP control, albuminuria was significantly associated with RMD in individuals with suboptimal BP (2.76[1.07–7.14], 0.037) but not in individuals with optimal BP (0.24[0.00–17.04],0.512)
Our study shows positive associations between albuminuria and RMD among West Africans with T2D, with the strength of association, accentuated in individuals with hypertension/suboptimal BP. Future studies could further characterize the role of hypertension in the associations between albuminuria and RMD.
Presence of retinopathy and incident kidney and cardiovascular events in type 2 diabetes with normoalbuminuria – A post-hoc analysis of the PRIORITY randomized clinical trial
2023, Journal of Diabetes and its Complications
Baseline diabetic retinopathy (DR) and risk of development of microalbuminuria, kidney function decline, and cardiovascular events (CVEs) in type 2 diabetes.
Post-hoc analysis of the PRIORITY study including 1758 persons with type 2 diabetes and normoalbuminuria followed for a median of 2.5 (IQR: 2.0–3.0) years. DR diagnosis included non-proliferative and proliferative abnormalities, macular oedema, or prior laser treatment. Cox models were fitted to investigate baseline DR presence with development of persistent microalbuminuria (urinary albumin-creatinine ratio > 30 mg/g); chronic kidney disease (CKD) G3 (eGFR <60 ml/min/1.73m²); and CVE. Models were adjusted for relevant risk factors.
At baseline, 304 (17.3 %) had DR. Compared to persons without DR, they were older (mean ± SD: 62.7 ± 7.7 vs 61.4 ± 8.3 years, p = 0.019), had longer diabetes duration (17.9 ± 8.4 vs. 10.6 ± 7.0 years, p < 0.001), and higher HbA_1c (62 ± 13 vs. 56 ± 12 mmol/mol, p < 0.001). The adjusted hazard ratios of DR at baseline for development of microalbuminuria (n = 197), CKD (n = 166), and CVE (n = 64) were: 1.50 (95%CI: 1.07, 2.11), 0.87 (95%CI: 0.56, 1.34), and 2.61 (95%CI: 1.44, 4.72), compared to without DR.
Presence of DR in normoalbuminuric type 2 diabetes was associated with an increased risk of developing microalbuminuria and CVE, but not with kidney function decline.
Albuminuria, Cognitive Impairment, and Structural Brain Disease: Connecting the Brain and Kidney
2023, Kidney Medicine
Microvascular complications: Diabetic eye disease
2023, BIDE's Diabetes Desk Book: For Healthcare Professionals
Aberrations in the retinal circulation lead to diabetic retinopathy. Major risk factors include uncontrolled chronic hyperglycemia and hypertension. Retinopathy can be classified as mild nonproliferative diabetic retinopathy (NPDR), moderate NPDR, severe NPDR, and proliferative diabetic retinopathy (PDR). Patients may present with floaters, distorted vision, and a gradual loss of visual acuity. Ophthalmoscopy helps in detecting microaneurysms, retinal and macular edema, hard exudates, cotton wool spots, venous loops and venous beading, and intraretinal microvascular abnormalities (IRMAs). Screening for diabetic retinopathy is essential for all individuals at the time of diagnosis of T2DM, after 5 years of diagnosis of T1DM, and annually thereafter. Women with T1DM or T2DM must undergo an ophthalmic examination before pregnancy or during the first trimester. The recommended investigations are fluorescent angiography, optical coherence tomography angiography (OCTA), optical coherence tomography (OCT) scans, and B-Scan ultrasonography. Management includes panretinal laser photocoagulation, intravitreal injections of antivascular endothelial growth factors (such as bevacizumab, ranibizumab, and aflibercept), intravitreal corticosteroids (e.g., triamcinolone acetonide), and vitrectomy.
Retinopathy prediction in type 2 diabetes: Time-varying Cox proportional hazards and machine learning models
2023, Informatics in Medicine Unlocked
Diabetic retinopathy (DR) is one of the most common complications in type 2 diabetes (T2D) with an estimated prevalence of 22%. Predictive modelling has largely been dependent on Cox proportional hazards (CPH) with assumptions of linearity and constant hazards. Machine learning (ML) approaches may prove advantageous in more adequately capturing non-linear effects.
To construct and compare DR prediction models using CPH and ML models with time-varying covariates.
Real-world, retrospective cohort study.
A tertiary care hospital in Thailand.
Data on 48,622 T2D patients from electronic health records between 1^st January 2010 and 31^st December 2019.
Time-to-event time-varying models that included 13 variables were trained in diabetic retinopathy prediction. The CPH and ML models were compared using left-truncated right censoring relative risk forest (LTRC-RRF) and left-truncated right censoring conditional inference forest (LTRC-CIF) algorithms.
The CPH model outperformed both ML approaches with a Harrell's C-index (c-index) of 0.70 compared to c-indices of 0.51–0.57 for the ML models in the test dataset. Both CPH and ML models showed insulin use and the presence of chronic kidney disease increased DR risk. Sodium glucose transporter 2 inhibitors and dyslipidemia were associated with reduced DR risk.
CPH provided better predictive power for DR risk than ML modelling using real world data. The presence of comorbidities and the use of antidiabetic medications were associated with the greatest drivers of DR risk.
Diabetic retinopathy in well-controlled type 2 diabetes: Role of glycaemic memory
2021, Diabetes and Metabolism
Citation Excerpt :
Diabetic retinopathy (DR) is the most frequent cause of blindness in adults before the age of 50 years in developed countries [1]. Even though the risk of DR is increased in patients with type 2 diabetes (T2D) and diabetic nephropathy [2], arterial hypertension and dyslipidaemia, its most consistent risk factor is, in fact, chronic hyperglycaemia [3]. Yet, glucose control is not commonly recommended for reducing the risk and progression of DR [4].
As diabetic retinopathy (DR) can occur even in well-controlled patients with type 2 diabetes (T2D), our study sought to determine whether it might be related to ‘glucose memory’ by evaluating patients’ HbA1c over previous years and their skin autofluorescence (SAF).
In 334 patients with T2D and HbA1c levels ≤ 8%, their available values of HbA1c from previous years were collected, and their SAF measured by an advanced glycation end-product (AGE) reader. Binary logistic regression analysis was then used to correlate DR with previously recorded HbA1c levels and to SAF, with adjustment for DR risk factors [age, gender, BMI, duration of diabetes, arterial hypertension, diabetic kidney disease (DKD), blood lipid levels and statin treatment].
Our patients were mostly men (58.4%) aged 63 ± 10 years, with a duration of diabetes of 13 ± 10 years and HbA1c = 7.1 ± 0.7%. Of these patients, 84 (25.1%) had DR, which was associated with longer duration of diabetes and greater prevalence of DKD. A total of 605 HbA1c values from previous years were collected for time periods −4 ± 3 months (n = 255), −16 ± 4 months (n = 152), −30 ± 4 months (n = 93) and −62 ± 26 months (n = 105). After adjustment, the association between DR and having an HbA1c higher than the median was significant only for the oldest previous HbA1c values: OR = 6.75, 95% CI: 1.90–23.90. Moreover, SAF values were higher in those with DR [2.95 ± 0.67 arbitrary units (AU)] vs 2.65 ± 0.65 AU with no DR (P < 0.01) and were also associated with the oldest previous HbA1c values (P < 0.01).
Our study found that 25.1% of our well-controlled T2D patients had DR, which was related to both their HbA1c levels from 5 years prior to study admission and their SAF values, a marker of glucose memory.

View all citing articles on Scopus

View full text